drug news

Building on its commitment to help life sciences and healthcare organizations discover, develop, and market innovative products and services that prevent and cure disease, Oracle today announced Oracle® Clinical Development Analytics.

Amid all the speculation over what course the Swine Flu epidemic will take, Boston-based biotech firm Replikins Ltd. last week analyzed the most recent peptide genomic sequence data available and determined that the infectivity of the H1N1 virus will increase markedly, while its lethality will remain relatively low for the immediate future.

The FDA is particularly concerned because a number of the drugs are for serious diseases and could have an adverse effect on treatment.

Researchers at The University of Texas Medical School at Houston are studying a number of medications that may help restore the fragile balance of chemicals or neurotransmitters in the brain destroyed by cocaine abuse, making recovery more possible.

Drug abusers who used a computer-assisted training program in addition to receiving traditional counseling stayed abstinent significantly longer than those who received counseling alone, a Yale University study has found.

Researchers have long searched for a novel cancer drug that activates a certain protein to kill tumor cells. But finding a drug that kills the cancer without causing damage to normal cells has stymied researchers.

MIT researchers and colleagues have created a waterproof adhesive bandage inspired by gecko lizards that may soon join sutures and staples as a basic operating room tool for patching up surgical wounds or internal injuries.

The AIDS Institute, a national public policy research, advocacy, and education organization, is encouraged with the FDA's approval of the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) in nearly a decade.

The Food and Drug Administration today issued its second safety warning about the fentanyl transdermal system, an adhesive patch that delivers a potent pain medicine through the skin.

Bystolic is a beta blocker, a well-established class of medications that reduces blood pressure by reducing the force with which the heart pumps.

Two international leaders in cancer research and drug development have announced completion of master agreements that will more effectively accelerate translational research and ultimately, bring new cancer drugs to patients faster.

The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

MIT researchers have discovered a link between a gene believed to promote long lifespan and a pathway that flushes cholesterol from the body.

The U.S. Food and Drug Administration today approved the first generic versions of Trileptal (oxcarbazepine), an anticonvulsant drug.

A previously unknown side effect of an unnamed drug currently on the marketplace could be useful for treating acne, reports Chemistry & Industry, the magazine of the SCI.

A new drug dosing system controlled by light has been developed by scientists at Queen's University Belfast. The system could allow the long-sought ability to deliver drugs where, when, and in the exact doses, required.

The mother of late wrestler CHRIS BENOIT has blamed U.S. federal agents for her son's death.

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to market Tamiflu(R) (oseltamivir phosphate) capsules in 30 mg and 45 mg doses.

At a meeting held Thursday, Food and Drug Administration's (FDA) Office of Cellular, Tissue and Gene Therapies Advisory Committee said that there is substantial evidence of efficacy and safety of Dendreon Corp.'s Provenge (sipuleucel-T) for the treatment of patients with prostate cancer.

Roche said Friday it filed an application with the U.S. Food and Drug Administration(FDA) to approve capsule Tamiflu doses for children.